课题基金 / 基金详情

Improving cardiovascular risk prediction in patients with glomerular disease

Improving cardiovascular risk prediction in patients with glomerular disease
改善肾小球疾病患者的心血管风险预测
批准号：
452322
负责人：
Barbour Sean
金额：
$17.22万
依托单位：
Providence Health Care Research Institute (Vancouver, BC)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=452322&lang=en
关键词：
Cardiovascular Disease Focal Segmental Glomerulosclerosis Framingham Risk Score Glomerulonephritis Iga Nephropathy Membranous Nephropathy Minimal Change Disease Prediction Models

项目摘要

项目成果

Barbour Sean的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Glomerulonephritis (GN) is a group of autoimmune diseases that attack the kidneys and is the second most common cause of kidney failure requiring dialysis or a kidney transplant in Canada. Unlike most other kidney diseases, GN mainly affects younger and o
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a personalized medicine approach to corticosteroid treatment in IgA nephropathy
The derivation, validation and implementation of an international risk prediction tool in IgA nephropathy
海外基金